Connect with others who understand.

Sign up Log in
About MyEndometrialCancerTeam
Powered By
Real members of MyEndometrialCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

How Effective Is Keytruda For Stage 4b

A MyEndometrialCancerTeam Member asked a question 💭
New York, NY
6 days ago
•
Be the first to like/hug
A MyEndometrialCancerTeam Member

Pembrolizumab (Keytruda) may be an effective treatment option for stage 4B endometrial cancer. According to the search results, pembrolizumab works by helping the immune system attack cancer cells. It may be used alone or combined with other treatments if previous therapies have not worked or if radiation or surgery are not Show Full Answer

Pembrolizumab (Keytruda) may be an effective treatment option for stage 4B endometrial cancer. According to the search results, pembrolizumab works by helping the immune system attack cancer cells. It may be used alone or combined with other treatments if previous therapies have not worked or if radiation or surgery are not options. The effectiveness likely depends on the specific details of each individual's cancer, such as whether the cancer cells have certain genetic features like deficient mismatch repair (dMMR). Testing cancer cells for these features can help determine if pembrolizumab may work.

6 days ago

Related content

View All

What Stage Of Endometrial Cancer Were You Diagnosed With, And How Did It Affect Your Treatment Options?

A MyEndometrialCancerTeam Member asked a question 💭
San Francisco, CA

CA125-crept Up To 44 (8/24) From 12 (3/24). Signatera 8/24 Positive At 0.13. CT Scan Didn't Show Anything. Wait/watch Or Chg Treatment?

A MyEndometrialCancerTeam Subscriber asked a question 💭

If One Does Not Have HEr2 Positive Advanced Endometrial Cancer, And Is Precribed Keytruda, Does One Generally Also Take Lenvima?

A MyEndometrialCancerTeam Subscriber asked a question 💭
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in